Common variable immune deficiency and lung transplantation.
We report on a male patient with bronchiectasis secondary to common variable immune deficiency (CVID) receiving lung transplantation. The patient had been diagnosed with CVID many y prior to right-sided single lung transplantation and was receiving appropriate immunoglobulin substitution therapy. He received antithymocyte globulin induction and maintenance triple therapy with cyclosporine, azathioprine and prednisolone. The early post-operative course was complicated by the development of severe acute cellular rejection and organizing pneumonia. Despite immunoglobulin replacement and antifungal prophylaxis and treatment, Aspergillus fumigatus was repeatedly cultured from bronchoalveolar lavage fluid, 18 months after transplantation. The patient died following a protracted period of repeated hospital admissions, 46 months after transplantation. A review of the literature suggests that many CVID patients appear to have had a complicated post-operative course after lung- and other solid-organ transplantation, and highlights the need for the establishment of international registries for transplanted patients with uncommon conditions.
Burton
Christopher M
CM
Division of Lung Transplantation, Department of Medicine B, University of Copenhagen, Denmark. cmburton@doctors.net.uk
Milman
Nils
N
Andersen
Claus B
CB
Marquart
Hanne
H
Iversen
Martin
M
D001228:Aspergillosis / Q000276:immunology* / Q000473:pathology; D001987:Bronchiectasis / Q000209:etiology; D017074:Common Variable Immunodeficiency / Q000150:complications / Q000601:surgery*; D017809:Fatal Outcome; D006801:Humans; D008172:Lung Diseases, Fungal / Q000276:immunology*; D016040:Lung Transplantation / Q000009:adverse effects* / Q000473:pathology; D008297:Male; D008875:Middle Aged